Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:8604
TSE:8604Capital Markets

Will Nomura’s New Lending Head Sharpen Its Regional Strategy or Highlight Structural Limits? (TSE:8604)

Nomura Holdings has appointed Etienne Broussaud, previously a managing director at UBS and formerly with Societe Generale, as head of lending and credit solutions for Southeast Asia, the Middle East, and Africa, based in Singapore and reporting to COO Sudhir Nemali. This hire brings deep experience in structured lending, risk solutions, and equity-related financing into Nomura’s wealth and investment businesses across several growth-focused regions. Next, we’ll examine how bringing in...
SGX:F03
SGX:F03Food

A Look At Food Empire Holdings (SGX:F03) Valuation After Mixed Full Year 2025 Earnings

Food Empire Holdings (SGX:F03) has just released its full year 2025 earnings, reporting sales of US$576.92 million compared with US$476.35 million a year earlier, while net income came in at US$35.99 million compared with US$52.53 million. See our latest analysis for Food Empire Holdings. The stock’s recent momentum has been strong, with a 30 day share price return of 18.18% and year to date share price return of 32.65%. The 1 year total shareholder return is also very large, suggesting the...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Is It Time To Reassess Freshpet (FRPT) After Its Recent Share Price Rebound?

If you are trying to figure out whether Freshpet at around US$84.45 is a bargain or already pricing in a lot of optimism, you are asking the right question for this stock. The share price performance has been mixed, with a 13.3% return over the last 7 days, 21.2% over 30 days, 40.4% year to date, but a 21.1% decline over 1 year and a 39.4% decline over 5 years. These swings mean recent news and expectations have become a big part of the story, as investors reassess what they are willing to...
TSX:PHX
TSX:PHXEnergy Services

Assessing PHX Energy Services (TSX:PHX) Valuation After Record Results Special Dividend And Analyst Upgrades

PHX Energy Services (TSX:PHX) is back in focus after reporting record fourth quarter and full year 2025 revenue, and pairing those results with a special $0.20 per share cash dividend to shareholders. See our latest analysis for PHX Energy Services. The share price reaction has been strong, with a 7 day share price return of 32.9% and a 90 day gain of 59.2% at a latest share price of CA$12.05. The 5 year total shareholder return is very large, signalling momentum that recent record results,...
TSE:4516
TSE:4516Pharmaceuticals

Should NS-863’s Dual Phase 2 Cardiopulmonary Push Require Action From Nippon Shinyaku (TSE:4516) Investors?

Nippon Shinyaku recently reported progress on two Phase 2 trials of its oral candidate NS-863, targeting pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, both serious cardiopulmonary conditions with high unmet need. By advancing NS-863 across two related indications, the company is signaling a deeper push into rare cardiopulmonary therapeutics, potentially broadening its specialty portfolio. We’ll now examine how this dual Phase 2 progress...
NYSE:URI
NYSE:URITrade Distributors

United Rentals Procore Telematics Link Aims To Deepen Customer Ties

United Rentals (NYSE:URI) and Procore Technologies launched a new telematics integration that brings rental equipment data directly into Procore's Resource Management solution. The collaboration connects jobsite equipment usage and location data with project planning tools to support more precise resource allocation. The integration is designed to help contractors address equipment inefficiencies and improve coordination across construction projects. For you as an investor, this move sits...
ASX:ASK
ASX:ASKSpecialized REITs

How Stronger Earnings And Reaffirmed Payouts At Abacus Storage King (ASX:ASK) Has Changed Its Investment Story

Abacus Storage King reported past half-year results to 31 December 2025, with sales of A$111.39 million and net income of A$71.08 million, both higher than a year earlier, and basic earnings per share from continuing operations of A$0.0541. The company also confirmed a first-half distribution of 3.10 cents per security and reaffirmed full-year 2026 distribution guidance of 6.20 cents per security, signalling consistency in returning cash to investors despite sector headwinds. We’ll now...
TSX:TSK
TSX:TSKMetals and Mining

Talisker Resources (TSX:TSK) Valuation Check After Upsized CA$52m Private Placement For Bralorne Project

Talisker Resources (TSX:TSK) just upsized its bought deal private placement to raise CA$52,000,000. The move is tied directly to investor demand and fresh funding plans for its Bralorne Gold Project in British Columbia. See our latest analysis for Talisker Resources. Despite the upsized financing and recent conference appearance, Talisker’s share price at CA$1.83 has seen a 16.44% 7 day share price decline and a 2.66% 1 day pullback. At the same time, its 1 year total shareholder return of...
NasdaqGS:CIFR
NasdaqGS:CIFRSoftware

Cipher Digital Pivot Tests New HPC Model And Hyperscaler Reliance

Cipher Digital, formerly focused on Bitcoin mining, has completed a full pivot to high performance computing infrastructure under the ticker NasdaqGS:CIFR. The company has rebranded, exited its legacy mining stakes, and repositioned itself as an operator of HPC data centers. Cipher Digital has secured long term data center agreements with major cloud providers including AWS, Fluidstack, and Google. The company has raised capital through bond offerings to support its shift toward hyperscale...
NasdaqGS:NSSC
NasdaqGS:NSSCElectronic

Is It Too Late To Consider Napco Security Technologies (NSSC) After A 93% One Year Rally?

If you are wondering whether Napco Security Technologies' current share price reflects its true worth, you are not alone. Many investors are trying to work out if the recent run still leaves room for value. The stock closed at US$46.61, with returns of 1.6% over the last 7 days, 26.3% over 30 days, 12.6% year to date and 92.9% over 1 year. The 3 year and 5 year returns stand at 47.4% and 182.8% respectively. Recent news coverage has largely focused on Napco Security Technologies as a...
TSX:GOLD
TSX:GOLDMetals and Mining

GoldMining (TSX:GOLD) Valuation After Crucero Resource Upgrade And New Antimony Potential

GoldMining (TSX:GOLD) has just released an updated Mineral Resource Estimate for its 100% owned Crucero Project in Peru, including first-time modeled antimony resources that change the overall picture of the deposit. See our latest analysis for GoldMining. GoldMining's recent Crucero update comes after a period in which the 1 year total shareholder return is 101.74%, while the year to date share price return is 36.47%. This suggests momentum building following a time that also included...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

Is NovoCure (NVCR) Pricing Look Out Of Step With Recent Share Rebound

If you are looking at NovoCure and wondering whether the recent share price makes sense, this article will walk through what that price might be implying about the stock's value. The shares last closed at US$13.67, with returns of 20.3% over the past 7 days and 10.2% over 30 days, set against a 4.2% return year to date and a 28.3% decline over 1 year, and an 82.5% and 89.4% decline over 3 and 5 years respectively. Recent news coverage around NovoCure has focused on the company as a Nasdaq...
NYSE:TRGP
NYSE:TRGPOil and Gas

Is It Too Late To Reassess Targa Resources (TRGP) After Strong Recent Share Gains?

If you are looking at Targa Resources and wondering whether the current share price still makes sense, you are not alone. The stock last closed at US$235.80, with returns of 1.9% over 7 days, 17.3% over 30 days, 26.3% year to date and 19.6% over 1 year, while the 3 year return is very large and the 5 year return is also very large. Recent news flow around Targa Resources has focused on its position in the energy infrastructure space and how investor sentiment has been reflecting that...
BME:ANE
BME:ANERenewable Energy

Did Acciona Energía’s 2025 Profit Jump Despite Lower Sales Just Shift Corporación Acciona Energías Renovables' (BME:ANE) Investment Narrative?

Corporación Acciona Energías Renovables, S.A. reported its full-year 2025 results on February 26, 2026, with sales of €2,925 million versus €3,048 million a year earlier, while net income rose to €655 million and basic earnings per share from continuing operations increased to €2 from €1.1. The combination of lower sales but much higher net income and earnings per share highlights a sharp improvement in underlying profitability and cost efficiency during 2025. With net income rising strongly...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Assessing Recursion Pharmaceuticals (RXRX) After A 51% One Year Share Price Decline

If you are wondering whether Recursion Pharmaceuticals' current share price makes sense, the key question is how that price compares with what the business could reasonably be worth. The stock last closed at US$3.67, with a 7 day return of 7.3%, a 30 day return decline of 12.4%, a year to date return decline of 12.6%, and a 1 year return decline of 51.1%. These figures will shape how many investors think about its potential and risk today. Recent coverage has focused on Recursion...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

Is GoodRx (GDRX) Using Employer Direct to Redefine Its Role in Workplace Drug Benefits?

GoodRx Holdings recently reported fourth-quarter 2025 results, issued 2026 revenue guidance of US$750 million to US$780 million, updated progress on its share buyback, filed a US$74.72 million shelf registration for an ESOP-related Class A stock offering, and disclosed several analyst rating changes. The company also launched GoodRx Employer Direct, a new program that lets employers directly subsidize high-cost drugs like GLP-1s at the pharmacy counter, potentially widening GoodRx’s role in...
NYSEAM:NHC
NYSEAM:NHCHealthcare

The Bull Case For National HealthCare (NHC) Could Change Following Strong 2025 Results And White Oak Acquisition

National HealthCare Corporation reported past fourth-quarter 2025 revenue of US$386.51 million and net income of US$24.85 million, with full‑year 2025 revenue of US$1.52 billion and net income of US$120.02 million, all higher than the prior year. The company highlighted that growth was supported both by higher same‑facility revenues and the contribution from its White Oak Manor acquisition, underscoring the role of expansion alongside core operations in its 2025 results. With this backdrop...
SEHK:2
SEHK:2Electric Utilities

Should CLP’s Higher Dividend and Renewables Push Amid Weaker Earnings Require Action From CLP Holdings (SEHK:2) Investors?

CLP Holdings Limited has released its audited full-year 2025 results, reporting revenue of HK$88,018 million and net profit of HK$10,667 million, both lower than the prior year, alongside earnings per share of HK$4.14 from continuing operations. Despite weaker earnings, the Board raised the total annual dividend to HK$3.20 per share and advanced its transition plans through new renewable projects, battery storage expansion, and the planned divestment of the Jhajjar coal-fired plant in...
TSE:6302
TSE:6302Machinery

Assessing Sumitomo Heavy Industries (TSE:6302) Valuation After New U.S. Navy Alliance In Japan

Sumitomo Heavy Industries (TSE:6302) just signed an Alliance Agreement with IMIA to support U.S. Navy operations in Japan, tying its industrial capabilities more closely to Pacific fleet maintenance and readiness needs. See our latest analysis for Sumitomo Heavy Industries. The new alliance headlines arrive after a strong run in the shares, with a 30 day share price return of 28.18% and a 1 year total shareholder return of 110.89%, suggesting that momentum has been building rather than...
NasdaqGS:PCRX
NasdaqGS:PCRXPharmaceuticals

Pacira BioSciences (PCRX) Valuation Check After Mixed Share Performance And High P/E Multiple

Why Pacira BioSciences is on investors’ radar today Pacira BioSciences (PCRX) has been drawing attention after a mixed share price pattern, with a 6.7% gain over the past month contrasting with negative returns over the past 3 months and year to date. See our latest analysis for Pacira BioSciences. At the current share price of $21.91, Pacira BioSciences shows a mixed picture, with a 6.7% 30 day share price return set against a 10.4% year to date share price decline and a 68.3% five year...
NasdaqGS:INTR
NasdaqGS:INTRBanks

Assessing Inter & Co (NasdaqGS:INTR) Valuation After Strong Multi‑Year Shareholder Returns

With no fresh headline driving Inter & Co (NasdaqGS:INTR) today, recent performance and fundamentals come into focus as investors weigh its returns profile against revenue of R$5,984.585 and net income of R$1,312.39. See our latest analysis for Inter & Co. Inter & Co’s share price has eased in the short term, with a 7 day share price return of 5.84% and 30 day share price return of 6.65%, yet its 1 year total shareholder return of 64.56% and 3 year total shareholder return of almost 4x...
NYSE:CON
NYSE:CONHealthcare

Earnings Beat, Dividend Hike, and Buybacks Might Change The Case For Investing In Concentra (CON)

Concentra Group Holdings Parent, Inc. recently reported its fourth-quarter and full-year 2025 results, with Q4 revenue rising to US$539.08 million and net income to US$34.69 million, while also declaring a US$0.0625 per-share cash dividend payable in March 2026. Management is pairing this earnings momentum with expansion plans focused on smaller, bolt-on acquisitions and a stepped-up de novo clinic pipeline, supported by a new US$100.00 million share repurchase program. We’ll now examine how...
XTRA:FTK
XTRA:FTKCapital Markets

Is Stronger 2025 Earnings and Higher Dividend Altering The Investment Case For flatexDEGIRO (XTRA:FTK)?

flatexDEGIRO SE has reported its fourth-quarter 2025 revenue of €149.4 million and net income of €39.9 million, with full-year 2025 revenue of €559.8 million and net income of €160.4 million, alongside a new capital allocation policy targeting an annual dividend equal to 20% of net income. The company’s plan to expand newer offerings such as crypto trading and securities lending, while sharply increasing its dividend payout, signals management’s confidence in the business model and its...
TSXV:AGAG
TSXV:AGAGMetals and Mining

Argenta Silver (TSXV:AGAG) Valuation Check After High Grade El Quevar Assay Results

Argenta Silver (TSXV:AGAG) just released a fresh batch of assay results from its 2025 to 2026 Summer Exploration Program at the El Quevar project, confirming high-grade silver intervals and extended mineralization around the Yaxtché deposit. See our latest analysis for Argenta Silver. Those assay results arrive after a strong run, with a 12.16% 7 day share price return and 16.90% 30 day share price return, while the 1 year total shareholder return sits at 225.49% despite a 7.26% 90 day share...